nonetheless, Even with similarity to THC in Substantially of its pharmacology, WIN55212-two differs from other courses of cannabinoids in its molecular interactions with cannabinoid receptors, obtaining not less than 1 exclusive website of attachment that is not shared by other cannabinoid agonists or from the CB1 antagonist rimonabant (Petitet et